Cubist Systematic Strategies, LLC Karyopharm Therapeutics Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 496,236 shares of KPTI stock, worth $317,591. This represents 0.0% of its overall portfolio holdings.

Number of Shares

496,236

Previous 568,975 12.78%

Holding current value

$317,591

Previous $495,000 16.97%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.7 - $1.06 $50,917 - $77,103	-72,739 Reduced 12.78%	496,236 $411,000
Q2 2024 Aug 14, 2024	BUY	$0.87 - $1.58 $495,008 - $898,980	568,975 New	568,975 $495,000
Q4 2023 Feb 14, 2024	BUY	$0.68 - $1.31 $3,185 - $6,136	4,684 New	4,684 $4,000
Q2 2023 Aug 14, 2023	BUY	$1.79 - $4.59 $286,407 - $734,418	160,004 New	160,004 $286,000
Q4 2022 Feb 14, 2023	BUY	$2.48 - $5.93 $996,082 - $2.38 Million	401,646 Added 454.54%	490,010 $1.67 Million
Q3 2022 Nov 14, 2022	SELL	$4.08 - $5.82 $416,629 - $594,309	-102,115 Reduced 53.61%	88,364 $482,000
Q2 2022 Aug 15, 2022	BUY	$4.15 - $8.37 $120,333 - $242,696	28,996 Added 17.96%	190,479 $859,000
Q1 2022 May 16, 2022	SELL	$5.91 - $14.38 $2.38 Million - $5.78 Million	-402,047 Reduced 71.34%	161,483 $1.19 Million
Q4 2021 Feb 14, 2022	BUY	$5.21 - $8.61 $2.44 Million - $4.03 Million	467,536 Added 487.05%	563,530 $3.62 Million
Q3 2021 Nov 15, 2021	BUY	$4.45 - $10.63 $217,965 - $520,668	48,981 Added 104.19%	95,994 $559,000
Q2 2021 Aug 16, 2021	BUY	$8.11 - $11.11 $138,121 - $189,214	17,031 Added 56.8%	47,013 $485,000
Q1 2021 May 17, 2021	BUY	$9.85 - $17.69 $295,322 - $530,381	29,982 New	29,982 $315,000
Q4 2020 Feb 16, 2021	SELL	$14.15 - $17.19 $1.24 Million - $1.5 Million	-87,543 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$14.14 - $19.71 $571,114 - $796,086	40,390 Added 85.66%	87,543 $1.28 Million
Q2 2020 Aug 14, 2020	BUY	$16.6 - $25.25 $444,664 - $676,371	26,787 Added 131.53%	47,153 $893,000
Q1 2020 May 15, 2020	SELL	$14.38 - $27.72 $664,844 - $1.28 Million	-46,234 Reduced 69.42%	20,366 $391,000
Q4 2019 Feb 14, 2020	BUY	$9.23 - $19.67 $614,718 - $1.31 Million	66,600 New	66,600 $1.28 Million
Q3 2019 Nov 14, 2019	SELL	$5.66 - $11.85 $478,292 - $1 Million	-84,504 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.32 - $6.43 $287,724 - $428,257	66,603 Added 372.06%	84,504 $506,000
Q1 2019 May 15, 2019	SELL	$4.12 - $10.25 $79,635 - $198,122	-19,329 Reduced 51.92%	17,901 $105,000
Q4 2018 Feb 14, 2019	BUY	$8.2 - $16.95 $141,704 - $292,912	17,281 Added 86.63%	37,230 $349,000
Q3 2018 Nov 14, 2018	BUY	$17.03 - $21.18 $192,268 - $239,122	11,290 Added 130.38%	19,949 $340,000
Q2 2018 Aug 14, 2018	SELL	$12.0 - $19.88 $200,712 - $332,512	-16,726 Reduced 65.89%	8,659 $147,000
Q1 2018 May 15, 2018	BUY	$9.92 - $17.25 $242,266 - $421,279	24,422 Added 2536.03%	25,385 $341,000
Q4 2017 Feb 14, 2018	BUY	$9.15 - $11.99 $8,811 - $11,546	963	963 $9,000

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Karyopharm Therapeutics Inc. Transaction History